Distribution Barriers May Reduce Biologic Drug Survival - Takeaways - MDSpire

Distribution Barriers May Reduce Biologic Drug Survival

A real‐world Brazilian registry suggests that challenges in biologic distribution were associated with treatment interruption, particularly among therapies requiring more frequent dosing.

By
Andrea Surnit
August 4, 2026
3 min

MDSpire News

Share

1

Distribution barriers may reduce biologic drug survival among patients with moderate-to-severe psoriasis.
2

Patients reporting medication distribution problems were more likely to discontinue biologic therapy.
3

Adalimumab was the most frequently prescribed biologic, followed by secukinumab and ustekinumab.
4

Approximately one-third of patients reported their biologic medication was out of stock during therapy.
5

The study acknowledged limitations due to its retrospective design and small sample size.